Foreign investors are resuming buying stocks in Keunwha Pharm, mainly due to higher ownership of major shareholders, stock analysts said.
Foreign investors increased their holding in Keunwha by 3.46 percent between January 1 and February 9, according to data from the Korea Stock Exchange (KRX).
"Domestic holdings of Keunwha shares had fallen to their lowest level in recent months. Major s...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.